🎉 Welcome to the Nasdaq family, Tempus AI! 🎉
🤖 $TEM harnesses the power of data and AI to drive precision medicine forward. Now they’re officially #NasdaqListed!
This is truly amazing and wonderful to see a Chicago biotech startup make it to this Milestone. Really proud of all the partners and patients who made this possible. Now, the race begins to get to #fastercures and ending cancer as we know it! Congratulations
Help healthcare entrepreneurs gain visibility & credibility in the right circles to accelerate their mission+profitability | HealthTech Broker | Human Capital Amplifier | Podcaster | Board Advisor | Author
Thank you for sharing, Heather Pilar Cunha Davis! Nasdaq, what upcoming innovations do you foresee making a significant impact in the field of precision medicine? Also, how do you envision Tempus AI's listing influencing the broader landscape of AI-driven healthcare solutions?
With #BioNeMo, researchers and developers can leverage generative #AI models with their proprietary data to rapidly predict the 3D structure and function of proteins and biomolecules
President at Engage Partners Inc. | Helping SMBs Use AI to Boost Productivity, Generate Leads, and Streamline Operations | AI Consultant | Making AI Easy and Impactful
'Blindsight' Innovation by Elon Musk
In a world where innovation knows no bounds, the recent announcement by Elon Musk regarding the FDA clearance for 'Blindsight' has left us all in awe. The Blindsight device from Neuralink is set to revolutionize the way blind individuals perceive the world around them. This groundbreaking technology will grant vision to those who have lost both eyes and their optic nerve, offering a glimpse into a future where possibilities are endless.
→ 𝑻𝒉𝒆 𝑷𝒐𝒘𝒆𝒓 𝑶f Technology: The Blindsight device opens up a realm of opportunities for individuals with visual impairments, showcasing the true power of technological advancements in enhancing human experiences.
→ 𝑨 𝑮limpse into the Future: While initially providing low-resolution vision, the potential for 'Blindsight' to surpass natural vision capabilities holds promise for a brighter tomorrow filled with newfound possibilities and independence.
→ 𝑰nnovation at its Finest: Elon Musk's relentless pursuit of innovation through Neuralink underscores the transformative impact that AI and technology can have on improving lives and reshaping our understanding of what is possible.
As someone deeply immersed in leveraging AI and cutting-edge strategies at Click2.ai, I am inspired by initiatives like 'Blindsight' that push boundaries and redefine what is achievable. Let's continue to embrace innovation and propel towards a future where limitations are but a distant memory.
Drug discovery is changing with the rapid growth of AI, the availability of more realistic drug screening environments, and the rise of precision medicine.
Here are the trends to know about: http://ms.spr.ly/6049iVNJ5
AI for target discovery: the start of a long road. In the fifth and final article in BioCentury's Back to School 2024, Editor in Chief Simone Fishburn and colleague write that investments in AI in drug discovery are picking up, as the picture starts to form of how target discovery may benefit
Did you know? Generative AI is not only creating art and content but also making strides in drug discovery. By simulating molecular structures, it accelerates the identification of potential medicines. The fusion of creativity and science is truly reshaping the future! 🧬🔍💡 #GenerativeAI#TechInnovation#BeyondArtistry
Leading Medical Researcher in Cancer and Global Health at University
4moThis is truly amazing and wonderful to see a Chicago biotech startup make it to this Milestone. Really proud of all the partners and patients who made this possible. Now, the race begins to get to #fastercures and ending cancer as we know it! Congratulations